- Home
- LMB vs AXGN Comparison
LMB vs AXGN Comparison
Compare LMB & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMB
- AXGN
- Stock Information
- Founded
- LMB 1901
- AXGN N/A
- Country
- LMB United States
- AXGN United States
- Employees
- LMB N/A
- AXGN N/A
- Industry
- LMB Engineering & Construction
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LMB Consumer Discretionary
- AXGN Health Care
- Exchange
- LMB Nasdaq
- AXGN Nasdaq
- Market Cap
- LMB 1.1B
- AXGN 1.2B
- IPO Year
- LMB 2014
- AXGN N/A
- Fundamental
- Price
- LMB $70.99
- AXGN $28.63
- Analyst Decision
- LMB Strong Buy
- AXGN Strong Buy
- Analyst Count
- LMB 2
- AXGN 7
- Target Price
- LMB $144.00
- AXGN $27.71
- AVG Volume (30 Days)
- LMB 204.1K
- AXGN 900.8K
- Earning Date
- LMB 11-04-2025
- AXGN 10-29-2025
- Dividend Yield
- LMB N/A
- AXGN N/A
- EPS Growth
- LMB 39.03
- AXGN N/A
- EPS
- LMB 3.03
- AXGN N/A
- Revenue
- LMB $603,582,000.00
- AXGN $214,709,000.00
- Revenue This Year
- LMB $28.57
- AXGN $21.57
- Revenue Next Year
- LMB $14.48
- AXGN $15.79
- P/E Ratio
- LMB $23.54
- AXGN N/A
- Revenue Growth
- LMB 16.56
- AXGN 18.72
- 52 Week Low
- LMB $63.02
- AXGN $9.22
- 52 Week High
- LMB $154.05
- AXGN $28.92
- Technical
- Relative Strength Index (RSI)
- LMB 36.77
- AXGN 83.29
- Support Level
- LMB $65.08
- AXGN $23.00
- Resistance Level
- LMB $70.78
- AXGN $28.92
- Average True Range (ATR)
- LMB 3.77
- AXGN 1.17
- MACD
- LMB 0.01
- AXGN 0.30
- Stochastic Oscillator
- LMB 40.70
- AXGN 94.26
About LMB Limbach Holdings Inc.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.